GraniteShares 3x Short AstraZeneca Daily ETC
Stock London Stock Exchange – Stock Market Prices, News & Analysis
Produit coté offrant une exposition quotidienne inverse et triple sur l’action AstraZeneca plc.
GraniteShares 3x Short AstraZeneca Daily ETC
Produit coté offrant une exposition quotidienne inverse et triple sur l’action AstraZeneca plc.
Price history of GraniteShares 3x Short AstraZeneca Daily ETC
Price history of GraniteShares 3x Short AstraZeneca Daily ETC
Performance & Momentum
Strategic Analysis
GraniteShares 3x Short AstraZeneca Daily ETC • 2026
This financial product provides inverse, triple-leveraged exposure to AstraZeneca shares, allowing investors to bet on a daily decline in the stock. It is designed for tactical investors seeking to hedge or speculate on short-term moves in the UK pharmaceutical sector.
- Targeted exposure to a major UK pharmaceutical stock
- Triple leverage to maximize potential gains from downward moves
- Exchange-traded product, facilitating liquidity and direct access to inverse leverage
- High volatility amplified by leverage and the inverse nature of the product
- Risk of rapid losses if the underlying stock enters a sustained uptrend
Very pronounced negative momentum across all time horizons reflects the structural depreciation of this product, inherent in its daily rebalancing mechanism and triple leverage. This dynamic confirms that it is strictly intended for tactical use and not as a long-term investment position.
Similar stocks to GraniteShares 3x Short AstraZeneca Daily ETC
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases